Gina Lohr

Senior Associate Vice Provost for Research, Gina M. Lohr

Gina Lohr has served in multiple roles within OVPR, most recently as Associate Vice President for Research. She is a Certified Research Administrator and has more than 12 years of experience in academic research administration at the George Washington University (GW).
Gina’s portfolio includes overseeing the Office of Sponsored Projects and its Research Enhancement Unit, management of core facilities, data management and analysis, human resources, budgeting, cross-disciplinary research initiatives, communications, systems innovation and overall OVPR operations.
Gina has served as a member of the GW Committee on Classification and Compensation, the GW President’s Council on Diversity and Inclusion, the university’s Sexual Assault Prevention and Response committee, the university’s Benefits Advisory Committee, and the planning committee for the grand opening of the Science and Engineering Hall.
Gina is an active volunteer with organizations that support survivors of sexual assault.





Associate Vice President, Research Integrity, Sheila Garrity

Sheila Garrity joined OVPR in June, 2014 and is tasked with providing highly visible and responsible leadership in the development and administration of institutional policies, procedures and programs as they relate to research integrity and compliance.  She will partner with key stakeholders around the institution to develop a strong research integrity infrastructure.  In her role, she oversees the operations of the Office of Laboratory and Radiation Safety; the Office of Human Research; the Animal Research Facilities; and Regulatory Affairs.

Ms. Garrity is a national leader in the fields of research integrity and the responsible conduct of research education. She comes to us after spending over 20 years at Johns Hopkins University School of Medicine where she most recently served as the Director of the Division of Research Integrity.  Ms. Garrity earned her MBA and MPH at Johns Hopkins where she also received a Certificate in Health and Human Rights and her JD from the University of Maryland School of Law.

Associate Vice President for Clinical and Translational Research, Lisa M. Guay-Woodford, M.D.

Lisa Guay-Woodford, MD is an internationally recognized expert in the field of polycystic kidney disease. Her major research effort focuses on identifying the genetic factors involved in the pathogenesis of autosomal recessive polycystic kidney disease (ARPKD). 

Dr. Guay-Woodford has a dual appointment at GW and Children's National Medical Center as the Director of the Center for Translational Science. She also serves as the Principal Investigator and Director of the Clinical and Translational Science Institute at Children's National (CTSI-CN).

Associate Vice President, Innovation and Entrepreneurship, James Chung

Jim Chung is the Associate Vice President for Innovation and Entrepreneurship at the George Washington University, and a co-principal investigator for the NSF Innovation Corps Node in Washington DC (DC I-Corps). He was previously the Director of the Mtech VentureAccelerator and the Founding Director of the Chesapeake Bay Seed Capital Fund at the University of Maryland. Prior to Mtech, he served as a Director for New Business Development at the Corporate Executive Board. He was also Vice President at Cherington Capital (now Intervale Capital), a middle market private equity firm in the oilfield equipment and services industry.

Jim started his private sector career as an early stage venture capital investor, most recently at incTANK Ventures, where he was the managing director. Some previous and current investments include Agamatrix, Nexaweb, Ulterra, Zymetis (now Aemetis), FlexEl, FiscalNote, and TravelBank. Before becoming an investor, Jim was an academic researcher studying how business, government, and academia work together to create new innovations in high technology industries. He has been a researcher at MIT, Harvard, University of Tokyo (Fulbright Fellow), ETRI (NSF EAPSI Fellow), STEPI (Korea), and KAIST. He was named in 2015 by Washingtonian Magazine as one of the Top 100 Tech Titans in DC and by Hot Topics as one of the Top 100 Entrepreneurship Professors worldwide.

Jim received his Bachelor’s and Master’s degrees from Stanford University and was a Ph.D. candidate at MIT.

Managing Director, Technology Commercialization Office, Steven Kubisen

Steve is a serial entrepreneur, corporate executive and university technology commercialization executive. He started his career in research and then moved to research management and general management for Union Carbide, Akzo Coatings, GE and Alcoa. During his eight years with GE, as General Manager of GE Electromaterials, he commercialized a revolutionary circuit board material for the emerging computer and telecommunications industries and as General Manager of R&D and Engineering of the $500M GE Silicones Division instituted systems to double new product sales.

As an entrepreneur, Steve was CEO of a revolutionary composite manufacturing venture and a medical device venture, in addition to serving on boards of a number of early stage ventures. Steve’s passion for commercializing early technologies and growing entrepreneurial communities led him to university technology commercialization operations.

For over seven years, he served as Vice President of Utah State University’s Office of Technology Commercialization and Senior Director of Ventures and the Medical Device/Software/Engineering Portfolio Group at the Johns Hopkins University. During his four-year tenure at Utah State, Steve tripled licensing revenue and moved the institution into the top five in the nation for start-ups per research dollar. During his three-year tenure at Hopkins, the institution increased start-ups from a historical annual level of four to 12 in 2008, with $76M venture capital raised.

Steve has an A.B. in chemistry from Cornell University and a Ph.D. in organic chemistry from Harvard University.